What are the recommended starting dose and titration schedule for lisinopril in adults, including considerations for hypertension, heart failure, renal impairment, and pregnancy?

Lisinopril Dosing Recommendations

Lisinopril is absolutely contraindicated throughout pregnancy and must be discontinued immediately in women who are pregnant or planning conception due to severe fetotoxicity, renal dysgenesis, and oligohydramnios. 1, 2, 3

---

Standard Adult Dosing for Hypertension

Start with 10 mg once daily in most adults with hypertension. 3

• Titrate according to blood pressure response to the usual maintenance range of 20-40 mg once daily 3
• Maximum studied dose is 80 mg daily, though doses above 40 mg do not appear to provide additional benefit 3

When Starting with Diuretics

If the patient is already taking a diuretic, reduce the starting dose to 5 mg once daily to minimize the risk of first-dose hypotension. 3

• After adding a diuretic to lisinopril monotherapy (e.g., hydrochlorothiazide 12.5 mg), you may be able to reduce the lisinopril dose 3

---

Heart Failure Dosing

Begin with 5 mg once daily when using lisinopril as adjunctive therapy with diuretics and digitalis for systolic heart failure. 3

Special Considerations in Heart Failure

• In patients with hyponatremia (serum sodium <130 mEq/L), start at 2.5 mg once daily 3
• Titrate upward as tolerated to a maximum of 40 mg once daily 3
• The appearance of hypotension after the initial dose does not preclude subsequent careful titration once hypotension is managed 3
• High-dose lisinopril (32.5-35 mg daily) is superior to low-dose (2.5-5 mg daily) for reducing morbidity and mortality in heart failure, with a 12% lower risk of death or hospitalization and 24% fewer heart failure hospitalizations 4, 5
• High doses are as well tolerated as low doses, with similar discontinuation rates despite higher rates of hypotension and renal function changes that are generally manageable 4, 5

---

Acute Myocardial Infarction Dosing

In hemodynamically stable patients within 24 hours of acute MI onset, give 5 mg orally, followed by 5 mg at 24 hours, 10 mg at 48 hours, then 10 mg once daily for at least 6 weeks. 3

Blood Pressure-Based Adjustments

• If systolic BP is ≤120 mmHg and >100 mmHg during the first 3 days post-infarct, start with 2.5 mg 3
• If hypotension occurs (systolic BP ≤100 mmHg), a maintenance dose of 5 mg daily may be given with temporary reductions to 2.5 mg if needed 3
• If prolonged hypotension occurs (systolic BP <90 mmHg for >1 hour), withdraw lisinopril 3

---

Renal Impairment Dosing

Creatinine Clearance >30 mL/min

No dose adjustment required. 3

Creatinine Clearance 10-30 mL/min

Reduce the initial dose to half the usual recommended dose: 3

• Hypertension: 5 mg once daily
• Heart failure: 2.5 mg once daily
• Acute MI: 2.5 mg once daily
• Titrate upward as tolerated to a maximum of 40 mg daily 3

Hemodialysis or Creatinine Clearance <10 mL/min

Start with 2.5 mg once daily. 3

Clinical Evidence in Renal Impairment

• Lisinopril provides effective blood pressure control in patients with GFR ≤60 mL/min without deterioration in renal function 6, 7
• In patients with severe renal failure (GFR <30 mL/min), starting with 2.5 mg prevents drug accumulation while maintaining adequate converting enzyme inhibition 7, 8
• The median effective dose in renal impairment studies was 10 mg daily (range 2.5-40 mg), with only a minority requiring addition of a diuretic 6, 7
• Drug accumulation occurs in severe renal failure but does not cause excessive antihypertensive effects; however, dose adjustment is recommended to avoid administering more than needed for adequate enzyme inhibition 8

---

Pediatric Dosing (Age ≥6 Years)

For children with GFR >30 mL/min/1.73m², start with 0.07 mg/kg once daily (maximum 5 mg total). 3

• Titrate according to blood pressure response up to a maximum of 0.61 mg/kg (not exceeding 40 mg) once daily 3
• Lisinopril is not recommended in children <6 years or with GFR <30 mL/min/1.73m² 3

---

Pregnancy: Absolute Contraindication

Critical Safety Information

ACE inhibitors including lisinopril are strictly contraindicated throughout all trimesters of pregnancy. 1, 2, 9

• Fetotoxic effects are especially pronounced during the second and third trimesters, causing renal dysgenesis, oligohydramnios, and a perinatal mortality rate of 97/1000 1, 9
• Women of childbearing potential taking lisinopril must have documented contraception or be switched to pregnancy-safe alternatives before conception attempts 1, 2

Pregnancy-Safe Alternatives

Switch immediately to extended-release nifedipine (preferred), labetalol, or methyldopa before conception or as soon as pregnancy is confirmed. 1, 2

• Extended-release nifedipine up to 120 mg daily is the preferred first-line agent due to once-daily dosing and superior safety data 1, 2
• Labetalol (up to 2400 mg/day in divided doses) is an excellent alternative, particularly for women without reactive airway disease 1, 2
• Methyldopa has the longest safety record with child follow-up to 7.5 years, but should be switched postpartum due to depression risk 1, 2

Exceptional Circumstance

• One case report documents a successful outcome when lisinopril was continued for refractory malignant hypertension in pregnancy after failed trials of labetalol, nifedipine, and methyldopa, but this required full counseling about the 97/1000 perinatal mortality rate and resulted in neonatal renal failure requiring 102 days of hospitalization 9
• This approach should only be considered when all pregnancy-safe alternatives have failed and the maternal risk of uncontrolled hypertension outweighs the severe fetal risks 9

---

Common Pitfalls to Avoid

• Never continue lisinopril in women planning pregnancy or who become pregnant—the fetotoxicity risk is unacceptable 1, 2, 9
• Do not start at full dose (10 mg) in patients already taking diuretics; use 5 mg to prevent first-dose hypotension 3
• Do not withhold higher doses in heart failure patients due to fear of side effects—high-dose therapy (32.5-35 mg) significantly reduces morbidity and mortality with manageable tolerability 4, 5
• In severe renal impairment (CrCl <30 mL/min), starting at standard doses causes unnecessary drug accumulation; always halve the initial dose 3, 8
• Do not assume elderly patients require lower doses based solely on age—dosage requirements (2.5-40 mg/day) are similar across age groups, though renal function must be assessed 10